Establishment Labs Holdings Inc ESTA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ESTA is a good fit for your portfolio.
News
-
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
-
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
-
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
-
Establishment Labs Announces Amended Credit Facility with Oaktree
-
Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28
-
Establishment Labs Announces Commercial Launch of Motiva Implants in China
Trading Information
- Previous Close Price
- $52.57
- Day Range
- $47.07–52.60
- 52-Week Range
- $16.96–77.55
- Bid/Ask
- $47.50 / $49.79
- Market Cap
- $1.30 Bil
- Volume/Avg
- 427,182 / 391,742
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 8.15
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 908
- Website
- https://establishmentlabs.com
Comparables
Valuation
|
Metric
|
ESTA
|
SYAB
|
06639
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 81.19 | — |
Price/Book Value | 74.55 | 0.99 | 1.79 |
Price/Sales | 8.15 | 0.88 | 1.90 |
Price/Cash Flow | — | 8.28 | 21.98 |
Price/Earnings
ESTA
SYAB
06639
Financial Strength
|
Metric
|
ESTA
|
SYAB
|
06639
|
|---|---|---|---|
Quick Ratio | 1.52 | 1.03 | 1.81 |
Current Ratio | 3.06 | 1.16 | 2.21 |
Interest Coverage | −4.17 | 2.17 | −2.38 |
Quick Ratio
ESTA
SYAB
06639
Profitability
|
Metric
|
ESTA
|
SYAB
|
06639
|
|---|---|---|---|
Return on Assets (Normalized) | −27.27% | 0.86% | −2.01% |
Return on Equity (Normalized) | −426.63% | 1.87% | −3.78% |
Return on Invested Capital (Normalized) | −26.53% | 2.44% | −2.01% |
Return on Assets
ESTA
SYAB
06639
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Twjbxzxwn | Zwydts | $182.7 Bil | |
SYK
| Stryker Corp | Htmhskpkb | Gpnv | $124.6 Bil | |
MDT
| Medtronic PLC | Fdvsdxpmh | Fqbwmb | $105.2 Bil | |
BSX
| Boston Scientific Corp | Rtyjpkhw | Krwfyb | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Zjwrynwt | Gdxpmch | $52.0 Bil | |
DXCM
| DexCom Inc | Yypyckmncv | Lwfcn | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Rchyjdlxg | Snpl | $24.5 Bil | |
ALGN
| Align Technology Inc | Tzxglcqdq | Lrlpnnl | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Vmxcjkv | Lykyp | $18.3 Bil | |
PODD
| Insulet Corp | Ddpllzxgqc | Kvbkgqm | $11.6 Bil |